NCT03562403

Brief Summary

The aim of this study is to observe the efficacy of Deep Brain Stimulation in the treatment of Parkinson's disease,Essential Tremors and Dystonia in our locality.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 19, 2018

Completed
12 days until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

June 19, 2018

Status Verified

June 1, 2018

Enrollment Period

9 months

First QC Date

May 22, 2018

Last Update Submit

June 18, 2018

Conditions

Keywords

deep brain stimulation

Outcome Measures

Primary Outcomes (1)

  • Change in the unified parkinson's disease rating scale score

    The Unified Parkinson's Disease Rating Scale (UPDRS) is a commonly used survey tool used to assess symptom severity of patients with Parkinson's disease (PD). It covers several different domains including 1) thought, behavior and mood 2) activities of daily living 3) motor activity 4) complications of therapy and others. Part I: evaluation of mentation, behavior, and mood Part II: self-evaluation of the activities of daily life (ADLs) including speech, swallowing, handwriting, dressing, hygiene, falling, salivating, turning in bed, walking, and cutting food Part III: clinician-scored monitored motor evaluation Part IV: complications of therapy Part V: Hoehn and Yahr staging of severity of Parkinson's disease Part VI: Schwab and England ADL scale

    baseline(pre-DBS )and 6 months post-DBS

Secondary Outcomes (1)

  • Change in antiparkinsonian medication use

    baseline(pre-DBS and 6 months post-DBS

Study Arms (1)

DBS on patients with abnormal movement disorders

EXPERIMENTAL

16 patients with intractable abnormal movement disorders (Parkinson's disease, Essential tremors and Dystonia)

Device: Deep Brain Stimulation

Interventions

stimulation of different basal ganglionic nuclei by a inserting a device

DBS on patients with abnormal movement disorders

Eligibility Criteria

Age25 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dopa responsiveness
  • Minimum disease duration of 5 years.
  • Diagnosis of idiopathic Parkinsons disease
  • Patients with intractable Essential Tremors.
  • Patients with intractable dystonia

You may not qualify if:

  • Significant medical health problems.
  • Significant cognitive impairment
  • Bleeding tendencies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Guttman M, Kish SJ, Furukawa Y. Current concepts in the diagnosis and management of Parkinson's disease. CMAJ. 2003 Feb 4;168(3):293-301.

  • Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery. 1995 Oct;37(4):680-6; discussion 686-7. doi: 10.1227/00006123-199510000-00011.

MeSH Terms

Conditions

Parkinson DiseaseEssential TremorDystonia

Interventions

Deep Brain Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsSurgical Procedures, Operative

Study Officials

  • Amr Elnaggar, MD

    University of Louisville

    STUDY DIRECTOR

Central Study Contacts

Ahmed Nouby, masters degree

CONTACT

Hanan Omar, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer in the Department of Neurosurgery

Study Record Dates

First Submitted

May 22, 2018

First Posted

June 19, 2018

Study Start

July 1, 2018

Primary Completion

April 1, 2019

Study Completion

July 1, 2019

Last Updated

June 19, 2018

Record last verified: 2018-06